Product Images Aubra Eq
View Photos of Packaging, Labels & Appearance
- Label - lbl636295651
- FIGURE I: Mean (SE) levonorgestrel and ethinyl estradiol serum concentrations in 22 subjects receiving levonorgestrel and ethinyl estradiol (100 mcg levonorgestrel and 20 mcg ethinyl estradiol) - levo ethi fig1
- CIRCULATORY DISEASE MORTALITY RATES PER 100,000 WOMAN YEARS BY AGE, SMOKING STATUS AND ORAL-CONTRACEPTIVE USE - levo ethi fig2
- levo-ethi-fig3 - levo ethi fig3
- levo-ethi-fig4 - levo ethi fig4
- levo-ethi-fig5 - levo ethi fig5
- levo-ethi-fig6 - levo ethi fig6
- levo-ethi-fig7 - levo ethi fig7
- Chemical Structure - levo ethi str
Product Label Images
The following 9 images provide visual information about the product associated with Aubra Eq NDC 63629-5651 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label - lbl636295651
The text is a description of a medication called Aubra EQ which contains levonorgestrel and ethinyl estradiol. Each tablet contains 0.1 mg of levonorgestrel USP and 0.02 mg of ethinyl estradiol USP. It provides information on dosage, storage guidelines, manufacturer details, and a recommendation to keep the package out of reach of children due to lack of child resistance.*
FIGURE I: Mean (SE) levonorgestrel and ethinyl estradiol serum concentrations in 22 subjects receiving levonorgestrel and ethinyl estradiol (100 mcg levonorgestrel and 20 mcg ethinyl estradiol) - levo ethi fig1
CIRCULATORY DISEASE MORTALITY RATES PER 100,000 WOMAN YEARS BY AGE, SMOKING STATUS AND ORAL-CONTRACEPTIVE USE - levo ethi fig2
levo-ethi-fig3 - levo ethi fig3
The text provided includes mentions of various studies related to women's health and contraceptive use, such as the NICHD Women's Contraceptive Study, French E3N cohort Study, Shanghai Women's Health Study, Nurses Health Study, and Oxford Family Planning Association Study. It also indicates the years these studies were conducted and whether they focused on ever or current use of contraceptives. Additionally, there are effect estimates (OR/AR) included in the text.*
levo-ethi-fig4 - levo ethi fig4
This is a product label for Aubra EQ®, containing Levonorgestrel and Ethinyl Estradiol in tablet form. The tablets may be white to off-white in color. The label indicates that tablets in week 4 are inactive.*
levo-ethi-fig5 - levo ethi fig5
This text provides instructions for identifying the correct day label for different colored pills, specifically white to off-white and green. It also mentions placing a label and following instructions along with the days of the week listed for reference. Additionally, it features a specific medication name and dosage information for tablets in week 4.*
levo-ethi-fig6 - levo ethi fig6
This is a label from a pack of birth control pills named "Aubra EQ" containing Levonorgestrel and Ethinyl Estradiol Tablets USP 0.1 mg/0.02 mg. The pills in week 4 are inactive and colored white to off-white. The packaging includes arrows to indicate the days of the week.*
levo-ethi-fig7 - levo ethi fig7
This text provides instructions for placing labels on different days of the week for a specific medication. The labels seem to be either white or off-white in color, and there are some green labels as well. The specific medication mentioned is Aubra EQ® which contains Levonorgestrel and Ethinyl Estradiol Tablets USP 0.1 mg/0.02 mg. The labels should be placed according to the days of the week (MON, TUE, WED, THU, FRI, SAT, SUN).*
Chemical Structure - levo ethi str
Ethinyl Estradiol*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
